CareMax, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020
ASSETS
Current Assets
Cash
Restricted cash
Cash and cash equivalents
Accounts receivable, net
Inventory
Prepaid expenses
Warrants and prepaid expenses
Risk settlement assets
Risk settlement receivables
Related party receivables
Other current assets
Risk settlements due from providers
Due from related parties
Total Current Assets

Investments held in Trust Account
Property and equipment, net
Operating lease right-of-use assets
Goodwill, net
Intangible assets, net
Deferred debt issuance costs
Other assets
Total Assets

LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
Current Liabilities
Accounts payable
Accrued expenses
Franchise tax payable
Note payable - related party
Accrued interest payable
Current portion of long-term debt
Risk settlement liabilities
Related party liabilities
Related party debt, net
Current portion of third-party debt, net
Current portion of operating lease liabilities
Other current liabilities
Total Current Liabilities

Deferred underwriting commissions
Derivative liabilities
Long-term debt, net
Long-term operating lease liabilities
Contingent earnout liability
Other liabilities
Total Liabilities
Class A common stock, $0.0001 par value; 11,616,546 and 10,697,997 shares subject to possible redemption at $10.01 per share as of March 31, 2021 and December 31, 2020, respectively
STOCKHOLDERS' (DEFICIT) EQUITY
Class A common stock ($0.0001 par value; 8,333,333 shares authorized; 3,814,871 and 3,744,732 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively)
Class A common stock
Class B common stock
Total class A common stock ($0.0001 par value; 8,333,333 shares authorized; 3,814,871 and 3,744,732 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively)

Additional paid-in capital
Additional paid-in-capital
Accumulated deficit
Member units (no par value, 200 authorized, issued and outstanding at December 31, 2020)
Stockholders' Equity
Class A common stock
Total Stockholders' Equity
Members' equity
Total Stockholders' (Deficit) Equity

Total Liabilities and Stockholders' (Deficit) Equity

Comments